反応式
[F:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([CH3:10])[C:5]([CH:11]2[CH2:13][O:12]2)=[CH:4][CH:3]=1.[OH:14][CH:15]([C:23]1[CH:32]=[CH:31][C:26]2[C:27](=[O:30])[O:28][CH2:29][C:25]=2[C:24]=1[CH3:33])[CH2:16][N:17]1[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]1>CCO>[F:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([CH3:10])[C:5]([CH:11]([OH:12])[CH2:13][N:20]2[CH2:21][CH2:22][N:17]([CH2:16][CH:15]([OH:14])[C:23]3[CH:32]=[CH:31][C:26]4[C:27](=[O:30])[O:28][CH2:29][C:25]=4[C:24]=3[CH3:33])[CH2:18][CH2:19]2)=[CH:4][CH:3]=1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
6-Fluoro-2-methyl-3-oxiran-2-ylbenzonitrile (69.2 mg, 0.391 mmol), 5-(1-hydroxy-2-piperazin-1-ylethyl)-4-methyl-2-benzofuran-1(3H)-one (54.0 mg, 0.195 mmol) was dissolved in EtOH (5 ml) then microwaved at 150° C. for 1 hr. Evaporated off ethanol and the residue was purified by mass directed hplc to yield 6-fluoro-3-(1-hydroxy-2-{4-[2-hydroxy-2-(4-methyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)ethyl]piperazin-1-yl}ethyl)-2-methylbenzonitrile.
後処理
- customthen microwaved at 150° C. for 1 hr
- customEvaporated off ethanol
- customthe residue was purified by mass
出典と根拠
- ORDレコード
- ord-0d2cad5232504db89716d25ad2ae1c8d
- 出典データセット
- uspto-grants-2015_04
- 特許番号
- US09018211B2
関連ノート
読み込み中…